Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
Saved in:
| Title: | Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models. |
|---|---|
| Authors: | Marcus P; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Warrington J; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Zhang M; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Ankathatti-Munegowda M; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Wang XH; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Rashedi I; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Keating A; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. |
| Source: | PloS one [PLoS One] 2026 Apr 20; Vol. 21 (4), pp. e0347095. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
